Sort
82,697 grants matching “vaccine development”
The Malawi Clinical Trials Unit
$10,899,286Taha E Taha · Johns Hopkins University · U01 · FY2008 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: VACCINE MANUFACTURING AND TOXICOLOGY CORE
$10,890,088Matthew Johnson · Duke University · N01 · FY2023 · AI
CANCER AND LEUKEMIA GROUP B
$10,878,004University Of Chicago · U10 · FY2002 · CA
Laboratory Animal Research Support & Model Development
$10,846,878Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
University of North Carolina Global HIV Prevention and Treatment Clinical Trials
$10,846,231Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2014 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$10,842,162Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2009 · AI
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$10,841,570Joseph E Robertson · Oregon Health & Science University · P51 · FY2007 · RR
The WWAMI RCE for Biodefense and Emerging ID
$10,840,432Samuel I. Miller · University Of Washington · U54 · FY2006 · AI
The Malawi Clinical Trials Unit
$10,834,928Taha E Taha · Johns Hopkins University · U01 · FY2010 · AI
Development of Technologies to Facilitate the use and Response of Vaccines
$10,792,404Marc Joseph Gurwith · Paxvax, Inc. · N01 · FY2013 · AI
DUAL AFFINITY RE-TARGETING (DART) MOLECULES FOR HIV-1 SUPPRESSION
$10,790,360Jeffrey Nordstrom · Macrogenics, Inc. · N01 · FY2017 · AI
SDMC - IMPAACT Leadership Group
$10,780,619David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2020 · AI
New England Regional Center of Excellence in Biodefense and Emerging Infectious D
$10,756,628Dennis L. Kasper · Harvard Medical School · U54 · FY2009 · AI
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$10,751,449Joseph E Robertson · Oregon Health & Science University · P51 · FY2006 · RR
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$10,749,810Ted Ross · University Of Georgia · N01 · FY2020 · AI
Region VI Center for Biodefence and Emerging Infections
$10,700,953David H Walker · University Of Texas Med Br Galveston · U54 · FY2007 · AI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$10,700,042Ted Ross · University Of Georgia · N01 · FY2023 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A: Vaccine Center
$10,693,906Tony Moody · Duke University · N01 · FY2023 · AI
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
$10,683,569Joseph E Robertson · Oregon Health & Science University · P51 · FY2008 · RR
Region VI Center for Biodefence and Emerging Infections
$10,678,610David H Walker · University Of Texas Med Br Galveston · U54 · FY2008 · AI
Radiation Therapy Oncology Group
$10,630,221Walter John Curran · American College Of Radiology · U10 · FY2011 · CA
New England Regional Center of Excellence for Biodefens*
$10,609,215Harvard University (Medical School) · U54 · FY2005 · AI
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
$10,582,459Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2004 · CA
SERCEB Southeast Regional Centers of Excellence for Bio*
$10,563,935Philip Frederick Sparling · Duke University · U54 · FY2007 · AI
Development and Production of HIV Vaccines and Adjuvants
$10,557,332Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2023 · AI